Predicting Early and Late Readmissions Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

BACKGROUND: Postoperative readmissions not only burden the healthcare system but may also affect clinical outcomes of cancer patients. Despite this, little is known about readmissions after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), or their impact on survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Eui Whan, Wong, Jolene Si Min, See, Amanda Hui Min, Ong, Whee Sze, Tan, Chee Ann, Ong, Chin-Ann Johnny, Chia, Claramae Shulyn, Soo, Khee Chee, Teo, Melissa Ching Ching, Tan, Grace Hwei Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Peritoneal Surface Malignancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460494/
https://www.ncbi.nlm.nih.gov/pubmed/34304310
http://dx.doi.org/10.1245/s10434-021-10414-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460494/
https://www.ncbi.nlm.nih.gov/pubmed/34304310
http://dx.doi.org/10.1245/s10434-021-10414-2

Ejemplares similares